Skip to main content
OpenTrials
Completed

NCT Number: NCT05985603

Comparison of Mirror Therapy and Modified Constrain Induced Movement Therapy on Risk of Fall, Balance and Gait in Stroke

There will be a difference between modified constraint induced movement therapy and Mirror Therapy on lower limb for risk of fall, balance and gait in stroke patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Vascular Diseases

Age range

21 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Helping Hand Institute Of rehabilitation sciences

Mansehra, KPK, 21300, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A Hemiplegia due to unilateral stroke
  • Sub-acute and chronic stroke
  • Stroke survivors between 21 and 70 years old will be recruited
  • Both genders
  • NIH Stroke scale below 20
  • Mini-Mental State Examination above 24
  • Function in Sitting Test (FIST) above 42/56

Exclusion criteria

  • Patients with depression who will be unable to cooperate during treatment
  • Patients who cannot perform the active movement of limb due to prestroke muscoskeletal problems
  • Cardiopulmonary diseases which could hinder their ability to participate in rehabilitation
  • Spasticity of Modified Ashworth Scale (MAS) II or higher
  • Patients with Any neuron disease and Patients with lower-limb impairment caused by other neurological diseases or inability to comply with study protocol will be excluded.
  • Visual and auditory abnormalities

Treatment and study plan

CIMT Group

Other

In this group of patients CIMT technique will be used for treatment

Mirror Therapy group

Other

patient will perform movements in semi-reclined and sitting positions with the mirror placed between the two lower extremities.

Primary outcomes

  1. NIH Stroke Scale - NIHSS

    Time frame: 2,4,8 week

    It comprises of 15 items with each having responses scored on a 0-4 points scale. The overall score ranges from 0-42 points with higher scores specifying pronounced neurological deficits

  2. Mini-mental state examination

    Time frame: 2,4,8 week

    Cognitive status by the mini-mental state examination (mmse)Mini-Mental State Examination (MMSE) is a tool that can quickly diagnose if a person suffers from mild cognitive impairment (MCI) through answering questions in different cognitive domains. The MMSE demonstrates moderately high levels of reliability. It has been reported to be internally consistent

  3. POMA

    Time frame: 2,4,8 week

    After interventions POMA for assessing risk of fall will be used. The POMA is used to examine balance and mobility in the elderly (Tinetti 1986). This examination tool consists of the balance subscale (9 items, 16 points) and gait subscale (8 items, 12 points), totaling 28 points.

  4. Berg balance scale

    Time frame: 2,4,8 week

    A five-point scale, ranging from 0-4. "0" indicates the lowest level of function and "4" the highest level of function. Total Score = 0-56. Score of 41-56 = low fall risk, 21-40 = medium fall risk, 0-20 = high fall risk.

  5. 10 Meter walk test / 10mwt

    Time frame: 2,4,8 week

    Calculating Gait Speed - total distance/time. For example: if you did a 10-meter gait speed test and it took you 7 seconds, the equation would like: 10 meters / 7 seconds = 1.4 meters per second. The 10MWT intra-rater and inter-rater reliability were good (ICC between 0.76 until 0.9) and excellent (ICC > 0.9), respectively. The minimal detectable change for intra-rater reliability was 0.188 m/s.

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Aug 14, 2023
Registry last updated
Nov 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.